nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLCO2B1—Conjugated Estrogens—osteoporosis	0.165	0.19	CbGbCtD
Tolbutamide—SLCO2B1—Estradiol—osteoporosis	0.145	0.167	CbGbCtD
Tolbutamide—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0906	0.104	CbGbCtD
Tolbutamide—SLCO1A2—Estradiol—osteoporosis	0.0796	0.0915	CbGbCtD
Tolbutamide—SLC22A6—Conjugated Estrogens—osteoporosis	0.055	0.0632	CbGbCtD
Tolbutamide—CYP2C9—Estropipate—osteoporosis	0.0534	0.0614	CbGbCtD
Tolbutamide—CYP2C8—Raloxifene—osteoporosis	0.0511	0.0587	CbGbCtD
Tolbutamide—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0493	0.0567	CbGbCtD
Tolbutamide—CYP2C8—Cholecalciferol—osteoporosis	0.0394	0.0453	CbGbCtD
Tolbutamide—CYP2C19—Cholecalciferol—osteoporosis	0.0331	0.038	CbGbCtD
Tolbutamide—CYP2C8—Estradiol—osteoporosis	0.0318	0.0365	CbGbCtD
Tolbutamide—CYP2C9—Cholecalciferol—osteoporosis	0.0275	0.0316	CbGbCtD
Tolbutamide—CYP2C19—Estradiol—osteoporosis	0.0267	0.0306	CbGbCtD
Tolbutamide—CYP2C9—Estradiol—osteoporosis	0.0222	0.0255	CbGbCtD
Tolbutamide—Porphyria cutanea tarda—Estradiol—osteoporosis	0.0106	0.084	CcSEcCtD
Tolbutamide—Porphyria non-acute—Estradiol—osteoporosis	0.00998	0.0788	CcSEcCtD
Tolbutamide—Reaction gastrointestinal—Zoledronate—osteoporosis	0.006	0.0474	CcSEcCtD
Tolbutamide—Heartburn—Alendronate—osteoporosis	0.00418	0.033	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Estropipate—osteoporosis	0.00332	0.0262	CcSEcCtD
Tolbutamide—Eruption—Estradiol—osteoporosis	0.00251	0.0198	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Conjugated Estrogens—osteoporosis	0.00219	0.0173	CcSEcCtD
Tolbutamide—Pancytopenia—Etidronic acid—osteoporosis	0.00201	0.0159	CcSEcCtD
Tolbutamide—Abdominal distension—Estropipate—osteoporosis	0.00184	0.0146	CcSEcCtD
Tolbutamide—Abdominal distension—Alendronate—osteoporosis	0.00182	0.0143	CcSEcCtD
Tolbutamide—Agranulocytosis—Etidronic acid—osteoporosis	0.00176	0.0139	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Estradiol—osteoporosis	0.00176	0.0139	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Alendronate—osteoporosis	0.00165	0.013	CcSEcCtD
Tolbutamide—Abdominal distension—Ethinyl Estradiol—osteoporosis	0.00149	0.0118	CcSEcCtD
Tolbutamide—Erythema—Etidronic acid—osteoporosis	0.00147	0.0116	CcSEcCtD
Tolbutamide—Abdominal distension—Risedronate—osteoporosis	0.00146	0.0115	CcSEcCtD
Tolbutamide—Leukopenia—Etidronic acid—osteoporosis	0.00132	0.0104	CcSEcCtD
Tolbutamide—Pruritus—Calcium Acetate—osteoporosis	0.0013	0.0102	CcSEcCtD
Tolbutamide—Erythema—Estropipate—osteoporosis	0.00128	0.0101	CcSEcCtD
Tolbutamide—Abdominal distension—Zoledronate—osteoporosis	0.00126	0.00999	CcSEcCtD
Tolbutamide—Erythema—Alendronate—osteoporosis	0.00126	0.00992	CcSEcCtD
Tolbutamide—Erythema—Ibandronate—osteoporosis	0.00122	0.00966	CcSEcCtD
Tolbutamide—Abdominal distension—Conjugated Estrogens—osteoporosis	0.00122	0.00962	CcSEcCtD
Tolbutamide—Erythema—Calcitriol—osteoporosis	0.0012	0.00945	CcSEcCtD
Tolbutamide—Pancytopenia—Zoledronate—osteoporosis	0.00119	0.00942	CcSEcCtD
Tolbutamide—Agranulocytosis—Pamidronate—osteoporosis	0.00114	0.00904	CcSEcCtD
Tolbutamide—Nausea—Calcium Acetate—osteoporosis	0.00109	0.0086	CcSEcCtD
Tolbutamide—Dyspepsia—Etidronic acid—osteoporosis	0.00106	0.00836	CcSEcCtD
Tolbutamide—Agranulocytosis—Zoledronate—osteoporosis	0.00105	0.00825	CcSEcCtD
Tolbutamide—Thrombocytopenia—Raloxifene—osteoporosis	0.000987	0.0078	CcSEcCtD
Tolbutamide—Abdominal distension—Estradiol—osteoporosis	0.000975	0.0077	CcSEcCtD
Tolbutamide—Nausea—Ergocalciferol—osteoporosis	0.000962	0.00759	CcSEcCtD
Tolbutamide—Erythema—Pamidronate—osteoporosis	0.000958	0.00757	CcSEcCtD
Tolbutamide—Urticaria—Etidronic acid—osteoporosis	0.000956	0.00755	CcSEcCtD
Tolbutamide—Dyspepsia—Estropipate—osteoporosis	0.000916	0.00724	CcSEcCtD
Tolbutamide—Dyspepsia—Alendronate—osteoporosis	0.000903	0.00713	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Estropipate—osteoporosis	0.000899	0.0071	CcSEcCtD
Tolbutamide—Dyspepsia—Raloxifene—osteoporosis	0.000888	0.00701	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Estradiol—osteoporosis	0.000884	0.00698	CcSEcCtD
Tolbutamide—Dyspepsia—Ibandronate—osteoporosis	0.000879	0.00694	CcSEcCtD
Tolbutamide—Erythema—Zoledronate—osteoporosis	0.000875	0.00691	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000871	0.00687	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000862	0.00681	CcSEcCtD
Tolbutamide—Leukopenia—Pamidronate—osteoporosis	0.000858	0.00677	CcSEcCtD
Tolbutamide—Pruritus—Etidronic acid—osteoporosis	0.000851	0.00672	CcSEcCtD
Tolbutamide—Erythema—Conjugated Estrogens—osteoporosis	0.000843	0.00666	CcSEcCtD
Tolbutamide—Urticaria—Estropipate—osteoporosis	0.000827	0.00653	CcSEcCtD
Tolbutamide—Urticaria—Alendronate—osteoporosis	0.000815	0.00643	CcSEcCtD
Tolbutamide—Urticaria—Ibandronate—osteoporosis	0.000793	0.00626	CcSEcCtD
Tolbutamide—Leukopenia—Zoledronate—osteoporosis	0.000784	0.00619	CcSEcCtD
Tolbutamide—Urticaria—Calcitriol—osteoporosis	0.000776	0.00613	CcSEcCtD
Tolbutamide—Thrombocytopenia—Pamidronate—osteoporosis	0.000766	0.00605	CcSEcCtD
Tolbutamide—Rash—Etidronic acid—osteoporosis	0.000759	0.00599	CcSEcCtD
Tolbutamide—Headache—Etidronic acid—osteoporosis	0.000754	0.00595	CcSEcCtD
Tolbutamide—Pruritus—Estropipate—osteoporosis	0.000737	0.00582	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000729	0.00575	CcSEcCtD
Tolbutamide—Pruritus—Alendronate—osteoporosis	0.000726	0.00573	CcSEcCtD
Tolbutamide—Dyspepsia—Risedronate—osteoporosis	0.000724	0.00572	CcSEcCtD
Tolbutamide—Nausea—Etidronic acid—osteoporosis	0.000715	0.00564	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Risedronate—osteoporosis	0.00071	0.00561	CcSEcCtD
Tolbutamide—Pruritus—Ibandronate—osteoporosis	0.000706	0.00558	CcSEcCtD
Tolbutamide—Thrombocytopenia—Zoledronate—osteoporosis	0.0007	0.00552	CcSEcCtD
Tolbutamide—Pruritus—Calcitriol—osteoporosis	0.000691	0.00546	CcSEcCtD
Tolbutamide—Dyspepsia—Pamidronate—osteoporosis	0.000689	0.00544	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000675	0.00533	CcSEcCtD
Tolbutamide—Erythema—Estradiol—osteoporosis	0.000675	0.00533	CcSEcCtD
Tolbutamide—Urticaria—Ethinyl Estradiol—osteoporosis	0.00067	0.00529	CcSEcCtD
Tolbutamide—Rash—Estropipate—osteoporosis	0.000656	0.00518	CcSEcCtD
Tolbutamide—Urticaria—Risedronate—osteoporosis	0.000654	0.00516	CcSEcCtD
Tolbutamide—Headache—Estropipate—osteoporosis	0.000652	0.00515	CcSEcCtD
Tolbutamide—Rash—Alendronate—osteoporosis	0.000647	0.0051	CcSEcCtD
Tolbutamide—Headache—Alendronate—osteoporosis	0.000642	0.00507	CcSEcCtD
Tolbutamide—Rash—Raloxifene—osteoporosis	0.000636	0.00502	CcSEcCtD
Tolbutamide—Headache—Raloxifene—osteoporosis	0.000632	0.00499	CcSEcCtD
Tolbutamide—Rash—Ibandronate—osteoporosis	0.00063	0.00497	CcSEcCtD
Tolbutamide—Dyspepsia—Zoledronate—osteoporosis	0.000629	0.00497	CcSEcCtD
Tolbutamide—Headache—Ibandronate—osteoporosis	0.000625	0.00494	CcSEcCtD
Tolbutamide—Nausea—Estropipate—osteoporosis	0.000618	0.00488	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000617	0.00487	CcSEcCtD
Tolbutamide—Rash—Calcitriol—osteoporosis	0.000616	0.00487	CcSEcCtD
Tolbutamide—Headache—Calcitriol—osteoporosis	0.000612	0.00483	CcSEcCtD
Tolbutamide—Nausea—Alendronate—osteoporosis	0.000609	0.00481	CcSEcCtD
Tolbutamide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000606	0.00478	CcSEcCtD
Tolbutamide—Nausea—Raloxifene—osteoporosis	0.000599	0.00473	CcSEcCtD
Tolbutamide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000597	0.00471	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000594	0.00469	CcSEcCtD
Tolbutamide—Nausea—Ibandronate—osteoporosis	0.000593	0.00468	CcSEcCtD
Tolbutamide—Pruritus—Risedronate—osteoporosis	0.000582	0.0046	CcSEcCtD
Tolbutamide—Nausea—Calcitriol—osteoporosis	0.000581	0.00458	CcSEcCtD
Tolbutamide—Urticaria—Zoledronate—osteoporosis	0.000568	0.00448	CcSEcCtD
Tolbutamide—Pruritus—Pamidronate—osteoporosis	0.000553	0.00437	CcSEcCtD
Tolbutamide—Urticaria—Conjugated Estrogens—osteoporosis	0.000547	0.00431	CcSEcCtD
Tolbutamide—Rash—Ethinyl Estradiol—osteoporosis	0.000532	0.0042	CcSEcCtD
Tolbutamide—Headache—Ethinyl Estradiol—osteoporosis	0.000529	0.00417	CcSEcCtD
Tolbutamide—Rash—Risedronate—osteoporosis	0.000519	0.0041	CcSEcCtD
Tolbutamide—Headache—Risedronate—osteoporosis	0.000515	0.00407	CcSEcCtD
Tolbutamide—Pruritus—Zoledronate—osteoporosis	0.000505	0.00399	CcSEcCtD
Tolbutamide—Nausea—Ethinyl Estradiol—osteoporosis	0.000501	0.00396	CcSEcCtD
Tolbutamide—Rash—Pamidronate—osteoporosis	0.000493	0.00389	CcSEcCtD
Tolbutamide—Headache—Pamidronate—osteoporosis	0.00049	0.00387	CcSEcCtD
Tolbutamide—Nausea—Risedronate—osteoporosis	0.000489	0.00386	CcSEcCtD
Tolbutamide—Pruritus—Conjugated Estrogens—osteoporosis	0.000487	0.00384	CcSEcCtD
Tolbutamide—Dyspepsia—Estradiol—osteoporosis	0.000485	0.00383	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000475	0.00375	CcSEcCtD
Tolbutamide—Nausea—Pamidronate—osteoporosis	0.000465	0.00367	CcSEcCtD
Tolbutamide—Rash—Zoledronate—osteoporosis	0.00045	0.00356	CcSEcCtD
Tolbutamide—Headache—Zoledronate—osteoporosis	0.000448	0.00353	CcSEcCtD
Tolbutamide—Urticaria—Estradiol—osteoporosis	0.000437	0.00345	CcSEcCtD
Tolbutamide—Rash—Conjugated Estrogens—osteoporosis	0.000434	0.00342	CcSEcCtD
Tolbutamide—Headache—Conjugated Estrogens—osteoporosis	0.000431	0.0034	CcSEcCtD
Tolbutamide—Nausea—Zoledronate—osteoporosis	0.000424	0.00335	CcSEcCtD
Tolbutamide—Nausea—Conjugated Estrogens—osteoporosis	0.000409	0.00323	CcSEcCtD
Tolbutamide—Pruritus—Estradiol—osteoporosis	0.00039	0.00308	CcSEcCtD
Tolbutamide—Rash—Estradiol—osteoporosis	0.000347	0.00274	CcSEcCtD
Tolbutamide—Headache—Estradiol—osteoporosis	0.000345	0.00272	CcSEcCtD
Tolbutamide—Nausea—Estradiol—osteoporosis	0.000327	0.00258	CcSEcCtD
Tolbutamide—CYP2C18—Biological oxidations—CYP19A1—osteoporosis	2.12e-05	0.00583	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—CYP19A1—osteoporosis	2.09e-05	0.00575	CbGpPWpGaD
Tolbutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.05e-05	0.00564	CbGpPWpGaD
Tolbutamide—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.02e-05	0.00556	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.95e-05	0.00536	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—GPX1—osteoporosis	1.93e-05	0.00531	CbGpPWpGaD
Tolbutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.83e-05	0.00503	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.81e-05	0.00498	CbGpPWpGaD
Tolbutamide—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.81e-05	0.00497	CbGpPWpGaD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	1.72e-05	0.00474	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.69e-05	0.00464	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—CYP27A1—osteoporosis	1.68e-05	0.00462	CbGpPWpGaD
Tolbutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.67e-05	0.00459	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.66e-05	0.00457	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CYP27A1—osteoporosis	1.66e-05	0.00456	CbGpPWpGaD
Tolbutamide—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.65e-05	0.00453	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.64e-05	0.00452	CbGpPWpGaD
Tolbutamide—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	1.57e-05	0.00432	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PKM—osteoporosis	1.54e-05	0.00424	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—FDPS—osteoporosis	1.54e-05	0.00424	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—ADCY5—osteoporosis	1.51e-05	0.00415	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	1.5e-05	0.00413	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PKM—osteoporosis	1.5e-05	0.00412	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—FDPS—osteoporosis	1.5e-05	0.00412	CbGpPWpGaD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.48e-05	0.00408	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	1.48e-05	0.00407	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—ADCY5—osteoporosis	1.47e-05	0.00403	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GPD2—osteoporosis	1.46e-05	0.00402	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PGLS—osteoporosis	1.46e-05	0.00402	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.43e-05	0.00393	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PGLS—osteoporosis	1.42e-05	0.0039	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GPD2—osteoporosis	1.42e-05	0.0039	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	1.37e-05	0.00376	CbGpPWpGaD
Tolbutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.35e-05	0.00372	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	1.35e-05	0.00371	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.34e-05	0.00369	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ATIC—osteoporosis	1.34e-05	0.00368	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PNP—osteoporosis	1.34e-05	0.00368	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.31e-05	0.00361	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ATIC—osteoporosis	1.3e-05	0.00357	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PNP—osteoporosis	1.3e-05	0.00357	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—POMC—osteoporosis	1.28e-05	0.00351	CbGpPWpGaD
Tolbutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.23e-05	0.00339	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—FDPS—osteoporosis	1.2e-05	0.00331	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PKM—osteoporosis	1.2e-05	0.00331	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GPD2—osteoporosis	1.14e-05	0.00313	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PGLS—osteoporosis	1.14e-05	0.00313	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—OXCT1—osteoporosis	1.14e-05	0.00313	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CA2—osteoporosis	1.14e-05	0.00313	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.12e-05	0.00309	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.12e-05	0.00307	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—MGLL—osteoporosis	1.11e-05	0.00305	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—OXCT1—osteoporosis	1.1e-05	0.00303	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CA2—osteoporosis	1.1e-05	0.00303	CbGpPWpGaD
Tolbutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.1e-05	0.00302	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—MGLL—osteoporosis	1.08e-05	0.00296	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.07e-05	0.00293	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PNP—osteoporosis	1.04e-05	0.00287	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ATIC—osteoporosis	1.04e-05	0.00287	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PKM—osteoporosis	1.02e-05	0.0028	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—FDPS—osteoporosis	1.02e-05	0.0028	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1e-05	0.00276	CbGpPWpGaD
Tolbutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1e-05	0.00276	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.99e-06	0.00275	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PGLS—osteoporosis	9.66e-06	0.00265	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GPD2—osteoporosis	9.66e-06	0.00265	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	9.51e-06	0.00261	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—IDH2—osteoporosis	9.43e-06	0.00259	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.15e-06	0.00251	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—IDH2—osteoporosis	9.14e-06	0.00251	CbGpPWpGaD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.92e-06	0.00245	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CA2—osteoporosis	8.87e-06	0.00244	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—OXCT1—osteoporosis	8.87e-06	0.00244	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP27A1—osteoporosis	8.87e-06	0.00244	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ATIC—osteoporosis	8.83e-06	0.00243	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PNP—osteoporosis	8.83e-06	0.00243	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	8.83e-06	0.00243	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.74e-06	0.0024	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	8.71e-06	0.00239	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.67e-06	0.00238	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—MGLL—osteoporosis	8.64e-06	0.00238	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ACP5—osteoporosis	8.62e-06	0.00237	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP27A1—osteoporosis	8.6e-06	0.00236	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ACP5—osteoporosis	8.36e-06	0.0023	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.29e-06	0.00228	CbGpPWpGaD
Tolbutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.13e-06	0.00224	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.12e-06	0.00223	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8.08e-06	0.00222	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TPI1—osteoporosis	8.02e-06	0.0022	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	7.88e-06	0.00217	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TPI1—osteoporosis	7.78e-06	0.00214	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	7.77e-06	0.00214	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—P4HB—osteoporosis	7.54e-06	0.00207	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—OXCT1—osteoporosis	7.51e-06	0.00206	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CA2—osteoporosis	7.51e-06	0.00206	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GAPDH—osteoporosis	7.4e-06	0.00203	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.4e-06	0.00203	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—IDH2—osteoporosis	7.35e-06	0.00202	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MGLL—osteoporosis	7.32e-06	0.00201	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.32e-06	0.00201	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—P4HB—osteoporosis	7.31e-06	0.00201	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.21e-06	0.00198	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—RAP1A—osteoporosis	7.21e-06	0.00198	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	7.19e-06	0.00198	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GAPDH—osteoporosis	7.18e-06	0.00197	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	7.09e-06	0.00195	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—RAP1A—osteoporosis	6.99e-06	0.00192	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP27A1—osteoporosis	6.91e-06	0.0019	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.9e-06	0.0019	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.79e-06	0.00187	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.74e-06	0.00185	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ACP5—osteoporosis	6.72e-06	0.00185	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.57e-06	0.00181	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.46e-06	0.00177	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TPI1—osteoporosis	6.25e-06	0.00172	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—IDH2—osteoporosis	6.22e-06	0.00171	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—P4HB—osteoporosis	5.87e-06	0.00161	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP27A1—osteoporosis	5.85e-06	0.00161	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ENO1—osteoporosis	5.83e-06	0.0016	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GAPDH—osteoporosis	5.76e-06	0.00158	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.76e-06	0.00158	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PSMA2—osteoporosis	5.74e-06	0.00158	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PSMA5—osteoporosis	5.74e-06	0.00158	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ACP5—osteoporosis	5.69e-06	0.00156	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ENO1—osteoporosis	5.65e-06	0.00155	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.62e-06	0.00154	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—RAP1A—osteoporosis	5.61e-06	0.00154	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PSMA5—osteoporosis	5.57e-06	0.00153	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PSMA2—osteoporosis	5.57e-06	0.00153	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.49e-06	0.00151	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.36e-06	0.00147	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—POMC—osteoporosis	5.31e-06	0.00146	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TPI1—osteoporosis	5.29e-06	0.00145	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.25e-06	0.00144	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.04e-06	0.00139	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PKM—osteoporosis	5.01e-06	0.00138	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—FDPS—osteoporosis	5.01e-06	0.00138	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—P4HB—osteoporosis	4.97e-06	0.00137	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.9e-06	0.00135	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GAPDH—osteoporosis	4.88e-06	0.00134	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—RAP1A—osteoporosis	4.76e-06	0.00131	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PGLS—osteoporosis	4.75e-06	0.0013	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GPD2—osteoporosis	4.75e-06	0.0013	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—POMC—osteoporosis	4.74e-06	0.0013	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP19A1—osteoporosis	4.66e-06	0.00128	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ENO1—osteoporosis	4.54e-06	0.00125	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP19A1—osteoporosis	4.52e-06	0.00124	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PSMA2—osteoporosis	4.47e-06	0.00123	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PSMA5—osteoporosis	4.47e-06	0.00123	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PKM—osteoporosis	4.47e-06	0.00123	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—FDPS—osteoporosis	4.47e-06	0.00123	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.47e-06	0.00123	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ATIC—osteoporosis	4.34e-06	0.00119	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PNP—osteoporosis	4.34e-06	0.00119	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—POMC—osteoporosis	4.32e-06	0.00119	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PGLS—osteoporosis	4.24e-06	0.00116	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GPD2—osteoporosis	4.24e-06	0.00116	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.15e-06	0.00114	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PKM—osteoporosis	4.07e-06	0.00112	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—FDPS—osteoporosis	4.07e-06	0.00112	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ATIC—osteoporosis	3.87e-06	0.00107	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PNP—osteoporosis	3.87e-06	0.00107	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PGLS—osteoporosis	3.86e-06	0.00106	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GPD2—osteoporosis	3.86e-06	0.00106	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ENO1—osteoporosis	3.84e-06	0.00106	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ADCY5—osteoporosis	3.81e-06	0.00105	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GPX1—osteoporosis	3.79e-06	0.00104	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PSMA2—osteoporosis	3.79e-06	0.00104	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PSMA5—osteoporosis	3.79e-06	0.00104	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CA2—osteoporosis	3.69e-06	0.00101	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—OXCT1—osteoporosis	3.69e-06	0.00101	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ADCY5—osteoporosis	3.69e-06	0.00101	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GPX1—osteoporosis	3.68e-06	0.00101	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP19A1—osteoporosis	3.63e-06	0.000998	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MGLL—osteoporosis	3.6e-06	0.000989	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PNP—osteoporosis	3.53e-06	0.000971	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ATIC—osteoporosis	3.53e-06	0.000971	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—MTHFR—osteoporosis	3.5e-06	0.000962	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—MTHFR—osteoporosis	3.39e-06	0.000933	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.39e-06	0.000932	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—OXCT1—osteoporosis	3.29e-06	0.000906	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CA2—osteoporosis	3.29e-06	0.000906	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MGLL—osteoporosis	3.21e-06	0.000883	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP19A1—osteoporosis	3.07e-06	0.000845	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—IDH2—osteoporosis	3.06e-06	0.000841	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.03e-06	0.000832	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—OXCT1—osteoporosis	3e-06	0.000826	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CA2—osteoporosis	3e-06	0.000826	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ADCY5—osteoporosis	2.96e-06	0.000815	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GPX1—osteoporosis	2.95e-06	0.000812	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MGLL—osteoporosis	2.93e-06	0.000805	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.88e-06	0.00079	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—POMC—osteoporosis	2.8e-06	0.00077	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ACP5—osteoporosis	2.8e-06	0.000769	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.76e-06	0.000759	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.76e-06	0.000759	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—IDH2—osteoporosis	2.73e-06	0.00075	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—MTHFR—osteoporosis	2.73e-06	0.00075	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—POMC—osteoporosis	2.71e-06	0.000746	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TPI1—osteoporosis	2.6e-06	0.000715	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.57e-06	0.000706	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ADCY5—osteoporosis	2.51e-06	0.00069	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GPX1—osteoporosis	2.5e-06	0.000688	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ACP5—osteoporosis	2.5e-06	0.000686	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—IDH2—osteoporosis	2.49e-06	0.000684	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.46e-06	0.000678	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—P4HB—osteoporosis	2.44e-06	0.000672	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GAPDH—osteoporosis	2.4e-06	0.00066	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.34e-06	0.000643	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—RAP1A—osteoporosis	2.34e-06	0.000643	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TPI1—osteoporosis	2.32e-06	0.000638	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MTHFR—osteoporosis	2.31e-06	0.000635	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ACP5—osteoporosis	2.28e-06	0.000626	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.25e-06	0.000618	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—P4HB—osteoporosis	2.18e-06	0.0006	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—POMC—osteoporosis	2.18e-06	0.000599	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GAPDH—osteoporosis	2.14e-06	0.000589	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TPI1—osteoporosis	2.12e-06	0.000582	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—RAP1A—osteoporosis	2.09e-06	0.000573	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.04e-06	0.00056	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—P4HB—osteoporosis	1.99e-06	0.000547	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GAPDH—osteoporosis	1.95e-06	0.000537	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—RAP1A—osteoporosis	1.9e-06	0.000523	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ENO1—osteoporosis	1.89e-06	0.000519	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PSMA2—osteoporosis	1.86e-06	0.000512	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PSMA5—osteoporosis	1.86e-06	0.000512	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—POMC—osteoporosis	1.85e-06	0.000508	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.82e-06	0.0005	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ENO1—osteoporosis	1.69e-06	0.000464	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PSMA2—osteoporosis	1.66e-06	0.000457	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PSMA5—osteoporosis	1.66e-06	0.000457	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.66e-06	0.000456	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ENO1—osteoporosis	1.54e-06	0.000423	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PSMA2—osteoporosis	1.52e-06	0.000417	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PSMA5—osteoporosis	1.52e-06	0.000417	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.51e-06	0.000415	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.35e-06	0.000371	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ADCY5—osteoporosis	1.23e-06	0.000339	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GPX1—osteoporosis	1.23e-06	0.000338	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.23e-06	0.000338	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTHFR—osteoporosis	1.13e-06	0.000312	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ADCY5—osteoporosis	1.1e-06	0.000303	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GPX1—osteoporosis	1.1e-06	0.000302	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTHFR—osteoporosis	1.01e-06	0.000278	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ADCY5—osteoporosis	1e-06	0.000276	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GPX1—osteoporosis	1e-06	0.000275	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTHFR—osteoporosis	9.24e-07	0.000254	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—POMC—osteoporosis	9.08e-07	0.00025	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—POMC—osteoporosis	8.1e-07	0.000223	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—POMC—osteoporosis	7.39e-07	0.000203	CbGpPWpGaD
